-
August 29, 2023 Over One-Third of Under 50s Are Open to Psychedelic Trials for Mental Health TreatmentAside from psilocybin, those aged between 18-24 were most interested psychedelic trials with ketamine (27%) and...
-
July 17, 2023 UK Psychedelic Trials Start-Up Issues National Call for Volunteers to Trial Innovative Medicines for Mental Health DisordersClerkenwell Health is today issuing a national call for volunteers to step forward for upcoming...
-
June 27, 2023 The FDA Issues Guidance on Designing Psychedelic Clinical TrialsThe Food and Drug Administration published a new draft guidance with the purpose to advise...
-
June 21, 2023 Will the UK’s Ambitious Life Sciences Investment Power-Up the Psychedelic Sector?As an emerging innovative sector addressing unmet mental health needs, psychedelic drug developers are poised...
-
May 4, 2023 Want to Try Psychedelics in a Clinical Setting? 116 Trials Now Recruiting Volunteers (UPDATED)Here's how to become a research subject for psilocybin, LSD, MDMA, ibogaine, DMT and 5-MeO-DMT...
-
April 25, 2023 Brain Scanning Technology to be Used for Psychedelic Clinical Trials in Pioneering London Start-Up PartnershipA start-up partnership between Clerkenwell Health and MYndspan will use brain scanning technology for psychedelic...
-
June 3, 2022 Psychedelic Business Spotlight – June 3This week in psychedelic business news: Cybin moves towards clinical trials; Braxia releases data on...
-
March 31, 2022 How to Enroll in a Psychedelic Clinical Trial in 5 Easy StepsInterested in participating in a psychedelic study? Here's an in-depth walk through guide so you...
